115 related articles for article (PubMed ID: 10451869)
1. Clinical pharmacokinetics of 123I-IAZA in healthy volunteers.
Stypinski D; Wiebe LI; McEwan AJ; Schmidt RP; Tam YK; Mercer JR
Nucl Med Commun; 1999 Jun; 20(6):559-67. PubMed ID: 10451869
[TBL] [Abstract][Full Text] [Related]
2. Dosimetry estimations for 123I-IAZA in healthy volunteers.
Stypinski D; McQuarrie SA; Wiebe LI; Tam YK; Mercer JR; McEwan AJ
J Nucl Med; 2001 Sep; 42(9):1418-23. PubMed ID: 11535735
[TBL] [Abstract][Full Text] [Related]
3. [131I]Iodoazomycin arabinoside for low-dose-rate isotope radiotherapy: radiolabeling, stability, long-term whole-body clearance and radiation dosimetry estimates in mice.
Kumar P; McQuarrie SA; Zhou A; McEwan AJ; Wiebe LI
Nucl Med Biol; 2005 Aug; 32(6):647-53. PubMed ID: 16026712
[TBL] [Abstract][Full Text] [Related]
4. [131I]IAZA as a molecular radiotherapeutic (MRT) drug: wash-out with cold IAZA accelerates clearance in a murine tumor model.
Mercer JR; McEwan AJ; Wiebe LI
Curr Radiopharm; 2013 Jun; 6(2):87-91. PubMed ID: 23551109
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and Scintigraphic Imaging of the Hypoxia-Imaging Agent [
Stypinski D; McQuarrie SA; McEwan AJB; Wiebe LI
Pharmaceutics; 2018 Feb; 10(1):. PubMed ID: 29470434
[TBL] [Abstract][Full Text] [Related]
6. Non-invasive assessment of human tumour hypoxia with 123I-iodoazomycin arabinoside: preliminary report of a clinical study.
Parliament MB; Chapman JD; Urtasun RC; McEwan AJ; Golberg L; Mercer JR; Mannan RH; Wiebe LI
Br J Cancer; 1992 Jan; 65(1):90-5. PubMed ID: 1310253
[TBL] [Abstract][Full Text] [Related]
7. Effects of methoxyflurane anesthesia on the pharmacokinetics of 125I-IAZA in Sprague-Dawley rats.
Stypinski D; Wiebe LI; Tam YK; Mercer JR; McEwan AJ
Nucl Med Biol; 1999 Nov; 26(8):959-65. PubMed ID: 10708311
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, radiolabeling, and biodistribution of putative metabolites of iodoazomycin arabinoside.
Lee HC; Kumar P; McEwan AJ; Wiebe LI; Mercer JR
Nucl Med Biol; 2000 Jan; 27(1):61-8. PubMed ID: 10755647
[TBL] [Abstract][Full Text] [Related]
9. A rapid and simple assay to determine the blood and urine concentrations of 1-(5-[123/125I]iodo-5-deoxyarabinofuranosyl)-2-nitroimidazole, a hypoxic cell marker.
Stypinski D; Wiebe LI; Mercer JR
J Pharm Biomed Anal; 1998 Feb; 16(6):1067-73. PubMed ID: 9547711
[TBL] [Abstract][Full Text] [Related]
10. Imaging of tumor hypoxia with [124I]IAZA in comparison with [18F]FMISO and [18F]FAZA--first small animal PET results.
Reischl G; Dorow DS; Cullinane C; Katsifis A; Roselt P; Binns D; Hicks RJ
J Pharm Pharm Sci; 2007; 10(2):203-11. PubMed ID: 17706178
[TBL] [Abstract][Full Text] [Related]
11. Radiation Dosimetry of Theragnostic Pairs for Isotopes of Iodine in IAZA.
Jans HS; Stypinski D; Kumar P; Mercer JR; McQuarrie SA; McEwan AJB; Wiebe LI
Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015281
[TBL] [Abstract][Full Text] [Related]
12. Radioiodinated 1-(5-iodo-5-deoxy-beta-D-arabinofuranosyl)-2-nitroimidazole (iodoazomycin arabinoside: IAZA): a novel marker of tissue hypoxia.
Mannan RH; Somayaji VV; Lee J; Mercer JR; Chapman JD; Wiebe LI
J Nucl Med; 1991 Sep; 32(9):1764-70. PubMed ID: 1880579
[TBL] [Abstract][Full Text] [Related]
13. Measurement of PDT-induced hypoxia in Dunning prostate tumors by iodine-123-iodoazomycin arabinoside.
Moore RB; Chapman JD; Mercer JR; Mannan RH; Wiebe LI; McEwan AJ; McPhee MS
J Nucl Med; 1993 Mar; 34(3):405-11. PubMed ID: 8441030
[TBL] [Abstract][Full Text] [Related]
14. Fast renal trapping of porcine luteinizing hormone (pLH) shown by 123I-scintigraphic imaging in rats explains its short circulatory half-life.
Klett D; Bernard S; Lecompte F; Leroux H; Magallon T; Locatelli A; Lepape A; Combarnous Y
Reprod Biol Endocrinol; 2003 Oct; 1():64. PubMed ID: 14585104
[TBL] [Abstract][Full Text] [Related]
15. Human biodistribution and dosimetry of [123I]FP-CIT: a potent radioligand for imaging of dopamine transporters.
Booij J; Busemann Sokole E; Stabin MG; Janssen AG; de Bruin K; van Royen EA
Eur J Nucl Med; 1998 Jan; 25(1):24-30. PubMed ID: 9396871
[TBL] [Abstract][Full Text] [Related]
16. Inhalation scintigraphy with iodine-123-labeled interferon gamma-1b: pulmonary deposition and dose escalation study in healthy volunteers.
Virgolini I; Kurtaran A; Leimer M; Smith-Jones P; Agis H; Angelberger P; Kletter K; Valent P; Linkesch W; Eichler HG
J Nucl Med; 1997 Sep; 38(9):1475-81. PubMed ID: 9293812
[TBL] [Abstract][Full Text] [Related]
17. Biodistribution and dosimetry study of 123I-rh-annexin V in mice and humans.
Lahorte CM; van de Wiele C; Bacher K; van den Bossche B; Thierens H; van Belle S; Slegers G; Dierckx RA
Nucl Med Commun; 2003 Aug; 24(8):871-80. PubMed ID: 12869819
[TBL] [Abstract][Full Text] [Related]
18. An evaluation of iodine-123 iodoazomycinarabinoside as a marker of localized tissue hypoxia in patients with diabetes mellitus.
al-Arafaj A; Ryan EA; Hutchison K; Mannan RH; Mercer J; Wiebe LI; McEwan AJ
Eur J Nucl Med; 1994 Dec; 21(12):1338-42. PubMed ID: 7875173
[TBL] [Abstract][Full Text] [Related]
19. Determination of tumour hypoxia with [18F]EF3 in patients with head and neck tumours: a phase I study to assess the tracer pharmacokinetics, biodistribution and metabolism.
Mahy P; Geets X; Lonneux M; Levêque P; Christian N; De Bast M; Gillart J; Labar D; Lee J; Grégoire V
Eur J Nucl Med Mol Imaging; 2008 Jul; 35(7):1282-9. PubMed ID: 18317752
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of 1-beta-D-(5-deoxy-5-iodoarabinofuranosyl)-2-nitroimidazole (beta-IAZA): a novel marker of tissue hypoxia.
Kumar P; Ohkura K; Beiki D; Wiebe LI; Seki K
Chem Pharm Bull (Tokyo); 2003 Apr; 51(4):399-403. PubMed ID: 12672991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
